Kingdoms wellness offerings include prescription-based therapies that are regulated and prescribed by licensed medical providers
David Sinclair, NMN has moved from the lab to the mainstream
AOD-9604 failed Phase 2 not due to adverse events but because the mean fat loss versus placebo, while statistically significant, was too modest for a standalone obesity treatment
The two strategies are therefore not substitutes, and they have very different evidence profiles
What distinguishes BPC-157 from many other research peptides is the breadth of biological systems in which it continues to be investigated
Products are sold for laboratory and research use only and are not intended for human consumption, injection, topical application, or any other administration to the human body